{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"pseudohypoaldosteronism-type-2a","columns":[{"gene":"","key":"population-d7f713039a17ecb32b8f","label":"Pseudohypoaldosteronism, type II","mondoId":"MONDO:0007772","onsetQualifier":null,"originColumnKey":"MONDO:0007772/OMIM:145260","originalViews":[{"key":"MONDO:0007772/OMIM:145260","label":"Pseudohypoaldosteronism, type II","scopeLabel":"OMIM:145260","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["61829962877e6e02f901636be07566540f7291658dc5b06499c573fdbd26c36a","ac86e568862e5d09355a56afba9867c146f4b8bdc293aa8fe545df6777ec709b","bf9f28780105e211a66374f411276337e61284f45ed99f83498091533510883d","fc2f0cc49b62d85dfd230bfd14ad6808e601bccb3e74443b25b1ccea19edb892","fdabb2f8952f5f0426375ed08f90c920f9a2374acad06e3867a602ca4534be67"],"recordQualifiers":{},"scopeLabel":"OMIM:145260","sourceIds":["OMIM:145260"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-d7f713039a17ecb32b8f"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0001995","HP:0002153","HP:0000822","HP:0007215","HP:0008242"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":5,"sourceGroups":{"omim":5}},"features":[{"hpoId":"HP:0001995","label":"Hyperchloremic acidosis","primary":true},{"hpoId":"HP:0002153","label":"Hyperkalemia","primary":true},{"hpoId":"HP:0000822","label":"Hypertension","primary":true},{"hpoId":"HP:0007215","label":"Periodic hyperkalemic paralysis","primary":true},{"hpoId":"HP:0008242","label":"Pseudohypoaldosteronism","primary":true}],"ledeHtml":"","mondoId":"MONDO:0007772","node":{"canonicalSlug":"pseudohypoaldosteronism-type-2a","comparisons":[{"documentSha256":"86f2a27f9a93fe6c4378e2bb19ff1b2e115dc7155fac5f17a279675191651708","key":"legacy-pseudohypoaldosteronism-type-2","kind":"legacy","label":"pseudohypoaldosteronism type 2","memberIds":["MONDO:0007772","MONDO:0013777","MONDO:0013778","MONDO:0013781","MONDO:0013782","MONDO:0019162"],"mondoId":"MONDO:0019162","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/pseudohypoaldosteronism-type-2.86f2a27f9a93fe6c4378e2bb19ff1b2e115dc7155fac5f17a279675191651708.json"}],"contexts":[],"lifecycle":"active","narrative":null,"ownColumnKeys":["population-d7f713039a17ecb32b8f"],"publication":"published","relationships":[{"kind":"parent","label":"pseudohypoaldosteronism type 2","mondoId":"MONDO:0019162","slug":"pseudohypoaldosteronism-type-2"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Public source record is not available in the frozen inputs","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/16775"}],"translation":"pending"},"records":[{"frequencyKind":"reported","key":"61829962877e6e02f901636be07566540f7291658dc5b06499c573fdbd26c36a","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:145260","disease_name":"Pseudohypoaldosteronism, type II","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0007215","is_excluded":false,"label":"Periodic hyperkalemic paralysis","onset_id":null,"reference":"OMIM:145260","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"ac86e568862e5d09355a56afba9867c146f4b8bdc293aa8fe545df6777ec709b","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:145260","disease_name":"Pseudohypoaldosteronism, type II","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001995","is_excluded":false,"label":"Hyperchloremic acidosis","onset_id":null,"reference":"OMIM:145260","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"bf9f28780105e211a66374f411276337e61284f45ed99f83498091533510883d","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:145260","disease_name":"Pseudohypoaldosteronism, type II","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0008242","is_excluded":false,"label":"Pseudohypoaldosteronism","onset_id":null,"reference":"OMIM:145260","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"fc2f0cc49b62d85dfd230bfd14ad6808e601bccb3e74443b25b1ccea19edb892","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:145260","disease_name":"Pseudohypoaldosteronism, type II","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002153","is_excluded":false,"label":"Hyperkalemia","onset_id":null,"reference":"OMIM:145260","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"fdabb2f8952f5f0426375ed08f90c920f9a2374acad06e3867a602ca4534be67","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:145260","disease_name":"Pseudohypoaldosteronism, type II","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000822","is_excluded":false,"label":"Hypertension","onset_id":null,"reference":"OMIM:145260","source_release":"2026-06-23"},"sourceGroups":["omim"]}],"referenceLabels":{},"references":{"causeHtml":"","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[],"sharedSources":[],"slug":"pseudohypoaldosteronism-type-2a","sourceDocuments":[],"sourceNote":"","synonyms":["PHA2A","pseudohypoaldosteronism, type IIA"],"takeawayHtml":"","title":"pseudohypoaldosteronism type 2A"},"schemaVersion":1}
